神经退行性疾病中的病毒载体:免疫反应和治疗应用
Yifei Wang1,2,3, Siyu Mu1,2,3, Fangxi Liu1,2,3
1Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Frontiers in neurology
|July 3, 2025
概括
病毒载体基因疗法通过修改基因或传递因子,对神经退行性疾病具有前景. 然而,对病毒载体的免疫反应仍然是成功治疗的关键挑战.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 使用病毒载体的基因转移疗法为神经退行性疾病提供了潜在的治疗方法.
- 机制包括基因沉默,替代和传递神经营养因子.
- 病毒载体在许多针对神经系统疾病的临床试验中正在被研究.
研究的目的:
- 审查病毒载体基因治疗神经退行性疾病的进展.
- 要总结与病毒载体使用相关的免疫反应.
- 为这个治疗领域提供未来前景.
主要方法:
- 关于病毒载体基因治疗的临床前和临床研究的文献综述.
- 对神经退行性疾病的基因修饰策略研究的分析.
- 对病毒载体的先天性和适应性免疫反应的检查.
主要成果:
- 病毒载体基因治疗显示出神经退行性疾病治疗的巨大潜力.
- 免疫反应,无论是先天的还是适应性的,都构成了主要的限制.
- 目前正在进行的研究集中在克服这些免疫挑战的新策略上.
结论:
- 病毒载体基因疗法是神经退行性疾病的一个有希望的途径.
- 了解和减轻免疫反应对于治疗成功至关重要.
- 需要进一步的研究来优化向量设计和临床应用的交付.
相关概念视频
Microorganisms in Medicine and Therapeutics
360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Immune Response Against Viral Pathogens
934
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
934
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265


